Research in Cancer Biotherapeutics is entering a new era with rapid and exciting developments taking place with many different approaches. This track on Immuno-Oncology will focus on innovations and progress in harnessing the body’s immune response to attack cancer and on overcoming inhibitory factors. Presentations will include engineering approaches and platform development, management of toxicity, enhancement of efficacy, and range from preclinical development and evaluation through IND to the clinic.
Further exciting and innovative advances in cancer research are presented in Novel Approaches for Cancer which covers engineering and development for bispecifics, ADCs, and fusion proteins. This event continues the strong focus on immune-response enhancing technologies. Data-rich presentations include platform development, engineering challenges, and technologies for target and lead selection, and cover measures to enhance potency, stability and resistance to aggregation. These studies cover early development through to pre-clinical evaluation.